Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space

seekingalpha06-29

The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2447612149?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160061727/image_1160061727.jpg","is_english":true,"pubTime":"2024-06-29 23:35","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2447612149","market":"fut","top_or_hot":-1,"title":"Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space","media":"seekingalpha","content":"<div>\n<p>The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which ...</p>\n\n<a href=\"https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-29 23:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which ...</p>\n\n<a href=\"https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SOLV","symbol_name":"Solventum","start_time":0,"source_url":"https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space","article_id":"2447612149","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160061727/image_1160061727.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2447612149","pubTimestamp":1719675300,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which ro","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SOLV":"Solventum","BK4082":"医疗保健设备","MOH":"Molina Healthcare Inc","IVV":"标普500指数ETF","VRTX":"福泰制药","BSX":"波士顿科学","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","VOO":"Vanguard标普500ETF","BK4154":"管理型保健护理","SSO":"两倍做多标普500ETF","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","WBA":"沃尔格林联合博姿","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓","FDN":"First Trust Dow Jones Internet I","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0109391861.USD":"富兰克林美国机遇基金A Acc","SDS":"两倍做空标普500ETF","OEF":"标普100指数ETF-iShares","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4532":"文艺复兴科技持仓","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","SPY":"标普500ETF",".SPX":"S&P 500 Index","SH":"标普500反向ETF","LLY":"礼来","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","CVS":"西维斯健康","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","MRNA":"Moderna, Inc.","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","PODD":"银休特","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","SPXU":"三倍做空标普500ETF","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0058720904.USD":"联博国际健康护理基金A","ALGN":"艾利科技","OEX":"标普100"},"translate_title":"Insulet在糖尿病领域获得市场份额，位居标普500第二季度增长榜首","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALGN":1,"WBA":1,"VRTX":1,"VOO":1,"SPY":1,"SOLV":1,"PODD":1,"MRNA":1,"MOH":1,"LLY":1,".SPX":1,"BSX":1,"CVS":1,"FDN":0.76,"OEF":0.6,"OEX":0.6,"SDS":0.6,"UPRO":0.6,"SH":0.6,"SPXU":0.6,"SSO":0.6,"ESmain":0.6,"IVV":0.6},"content_text":"The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which rose 4.30%. Insulet (PODD) saw the biggest growth in the S&P 500 healthcare index, rising about 25% as it continues to gain market share in the type 1 diabetes market. Eli Lilly (LLY) came in second, rising nearly 16.31%, as it continues to ride the weight loss frenzy. The overall sector saw a gradual drop in April as major pharmaceutical companies reported their earnings but has risen steadily till end of June with a slight dip in end of May. Industries Q2 performance The Health Care Equipment & Services sector and Pharmaceuticals, Biotechnology and Life Sciences fell 3.3% each in the second quarter of the year. The healthcare-focused ETF had a net flow of -$1.53M in the quarter. Top 5 S&P 500 healthcare performers in Q2: Insulet Corporation (PODD) +24.95% Eli Lilly and Company (LLY) +16.31% Moderna (MRNA) +14% Boston Scientific (BSX) +13.48% Vertex Pharmaceuticals (VRTX) +13.27% Bottom 5 S&P 500 healthcare performers in Q2: Solventum Corporation (SOLV) -36.56% Molina Healthcare (MOH) -27.29% Align Technology (ALGN) -23.86% Walgreens Boots Alliance (WBA) -23.65% CVS Health (CVS) -23.56% What Analysts Expect SA analyst John Bowman suggests, “The SPDR Healthcare Sector ETF is ripe for buying at the moment due to several factors, including inelastic demand for its products and services; stunted valuation, and recent underperformance compared to other sectors. There is a lot of room for growth in this sector as the population expands, health insurance coverage rises, and companies work toward refining their profit margins.” Bowman further adds, “There are some risks still present in the sector, such as the impending \"patent cliff\" that could cause a major loss in sales of name-brand drugs as they go generic, as well as shifting Medicare and Medicaid rules around prescription pricing.” Seeking Alpha analysts recommend a Buy for the sector. What Quantitative Measures Say XLV has a Buy rating from Seeking Alpha’s Quant Rating system with a 3.84 score out of 5. This comes largely from an A+ in liquidity and dividends, countered by a C in Risk and a B+ in Momentum.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2447612149"}